Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Jeanny Aragon-Ching, MD, FACP, of the Inova Schar Cancer Institute, Fairfax, Canada, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA, where she discusses the promising response rates in the use of the antibody-drug conjugate sacituzumab govitecan in the treatment of metastatic urothelial carcinoma from the TROPHY U-01 study (NCT03547973).
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.